Buoyed by High Demand in COVID-19 Pandemic, Dural Graft Market to Generate Heightened Revenue Prospects for Manufacturers in the Next Decade

Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products.

Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25285

Gain More Insights about this Report

Company Profiles

• By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
• Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
• Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
• Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
• Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
• Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25285

“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.

Brain and Spinal Tumor Application Dominating Dural Graft Market

Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes.

For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/25285

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Molecular Diagnostics Market –

Molecular Diagnostics Market Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Syndromes Progressive Ataxia Weakness Disorders Market – 

Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

Contact Information:

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
U.S. Phone - +1-646-568-7751
U.S.-Canada Toll-free : +1 800-961-0353
E-mail id - sales@persistencemarketresearch.com
Website : www.persistencemarketresearch.com